Litlamorao tsa nako e telele tsa COVID-19

Jennifer Mihas o ne a tloaetse ho phela bophelo bo mafolofolo, a bapala tennis le ho tsamaea ho pota Seattle.Empa ka Hlakubele 2020, o ile a etsa tlhahlobo ea COVID-19 mme esale a kula ho tloha ka nako eo.Ka nako eo o ne a khathetse ke ho tsamaea sebaka se bohōle ba limithara tse makholo, ’me o ne a se a hema ka thata, a tšoaroa ke migraine, arrhythmias le matšoao a mang a fokolisang.

Tsena ha se linyeoe tse ikhethang.Ho latela Litsi tsa US tsa Taolo le Thibelo ea Mafu, liperesente tse 10 ho isa ho tse 30 tsa batho ba tšoaelitsoeng ke SARS-CoV-2 ba ba le mathata a nako e telele a bophelo bo botle.Bongata ba bona joalo ka Mihas, matšoao ana a phehellang, a tsejoang ka hore ke sequelae e matla ea ts'oaetso ea SARS-CoV-2 (PASC) kapa, hangata, tatelano ea nako e telele ea COVID-19, e ka ba bonolo kapa e tebile ho lekana ho holofatsa, e amang hoo e ka bang tsamaiso efe kapa efe ya setho mmeleng.

news-2

Hangata batho ba amehileng ba tlaleha mokhathala o feteletseng le bohloko ba 'mele.Batho ba bangata ba lahleheloa ke kutlo ea bona ea tatso kapa monko, boko ba bona bo lieha ho sebetsa 'me ha ba khone ho tsepamisa mohopolo, e leng bothata bo tloaelehileng.Litsebi li tšoenyehile hore bakuli ba bang ba nang le sequelae ea nako e telele ea COVID-19 ba kanna ba se fole.

Joale, tatelano ea nako e telele ea COVID-19 e ntse e eketseha sebakeng se hlahelletseng.Ka Hlakola, Mekhatlo ea Naha ea Bophelo bo Botle e phatlalalitse morero oa $ 1.15 bilione ho fumana lisosa tsa sequelae ea nako e telele ea COVID-19 le ho fumana mekhoa ea ho thibela le ho phekola lefu lena.

Ho tloha bofelong ba Phuptjane, batho ba fetang limilione tse 180 ba ile ba fumana hore ba na le tšoaetso ea SARS-CoV-2, mme ba bang ba limilione tse makholo ba kanna ba tšoaetsoa ke SARS-CoV-2, ka litlhare tse ncha tse ntseng li etsoa ho sebetsana le palo e kholo ea batho. lipontšo tse ncha tse ka khonehang tsa bongaka.

PureTech Health e ntse e etsa tlhahlobo ea bongaka ea phase II ea mofuta oa deuterated oa pirfenidone, LYT-100.Pirfenidone e amoheloa bakeng sa idiopathic pulmonary fibrosis.Lyt-100 e lebisa tlhokomelo ea li-cytokine tsa pro-inflammatory, ho akarelletsa le IL-6 le TNF-α, 'me e fokotsa pontšo ea TGF-β ho thibela ho kenngoa ha collagen le ho thehoa ha lebali.

CytoDyn e ntse e leka mohanyetsi oa eona oa CC motactic chemokine receptor 5 (CCR5) leronlimab, antibody ea IgG4 ea motho ea monoclonal, tekong ea 2 ea batho ba 50.CCR5 e ameha mekhoeng e mengata ea mafu, ho kenyeletsa HIV, multiple sclerosis, le kankere ea metastatic.Leronlimab e lekiloe litekong tsa kliniki tsa phase 2B / 3 e le kalafo e eketsehileng bakeng sa lefu la phefumoloho ho bakuli ba kulang haholo ba nang le COVID-19.Liphetho li fana ka maikutlo a hore sethethefatsi se na le molemo oa ho phela ha se bapisoa le liphekolo tse sebelisoang hangata, 'me thuto ea hajoale ea 2 e tla etsa lipatlisiso ka moriana e le kalafo ea matšoao a fapaneng.

Ampio Pharmaceuticals e tlalehile liphetho tse ntle tsa mohato oa 1 bakeng sa cyclopeptide LMWF5A (aspartic alanyl diketopiperazine), e phekolang ho ruruha ho feteletseng matšoafong, 'me Ampio o bolela hore peptide e ekelitse lefu la lisosa tsohle ho bakuli ba nang le khatello ea maikutlo.Tekong e ncha ea Mokhahlelo oa 1, bakuli ba nang le matšoao a phefumoloho a nkang libeke tse 'ne kapa ho feta ba tla itlhokomela lapeng le nebulizer matsatsi a mahlano.

Synairgen e United Kingdom e sebelisitse mokhoa o ts'oanang ho kenyelletsa sequelae ea nako e telele ea COVID-19 tekong ea bongaka ea mohato oa 3 ea SNG001 (e hemang IFN-β).Liphello tse tsoang thutong ea 2 ea lithethefatsi li bontšitse hore SNG001 e ne e le molemo ho ntlafatso ea mokuli, ho hlaphoheloa, le ho tsoa ha ho bapisoa le placebo ka letsatsi la 28.


Nako ea poso: 26-08-21